Advances and challenges in the prevention and treatment of COVID-19
| Autor: | Yanjie Han, Chunyan Ma, Dongdong Wu, Zhiguang Ren, Xin-Ying Ji, Jiliang Yan, Xinxin Li |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
viruses
virological characteristics Review medicine.disease_cause Cyclophilins 0302 clinical medicine Epidemiology Respiratory system Coronavirus Antibodies Monoclonal virus diseases Chloroquine General Medicine Endocytosis clinical treatment Pyrazines 030211 gastroenterology & hepatology Coronavirus Infections medicine.medical_specialty Interferon Inducers Coronavirus disease 2019 (COVID-19) Chlorpromazine Middle East respiratory syndrome coronavirus Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pneumonia Viral Antiviral Agents Betacoronavirus 03 medical and health sciences Drug Development medicine Humans Pandemics Nucleic Acid Synthesis Inhibitors SARS-CoV-2 business.industry Immune Sera Drug Repositioning COVID-19 Outbreak Viral Vaccines medicine.disease Amides Virology COVID-19 Drug Treatment respiratory tract diseases Pneumonia Resveratrol business drugs Drugs Chinese Herbal |
| Zdroj: | International Journal of Medical Sciences |
| ISSN: | 1449-1907 |
| Popis: | Since the end of 2019, a new type of coronavirus pneumonia (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has been spreading rapidly throughout the world. Previously, there were two outbreaks of severe coronavirus caused by different coronaviruses worldwide, namely Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). This article introduced the origin, virological characteristics and epidemiological overview of SARS-CoV-2, reviewed the currently known drugs that may prevent and treat coronavirus, explained the characteristics of the new coronavirus and provided novel information for the prevention and treatment of COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|